Sartorius acquires cell culture specialist Xell AG

por Sartorius Stedim Spain

Extension of the Sartorius cell culture media business with a focus on media for gene therapeutics and vaccines

Leer más

Sartorius expands production capacities for products for the purification of vaccines and therapeutics in Slovenia

por Sartorius Stedim Spain

Ribbon cutting attended by the Prime Minister of the Republic of Slovenia, Janez Janša Innovative products for the purification of advanced agents such as mRNA or adenoviruses for the manufacture of...

Leer más

Fighting Cancer with Personalized Vaccines: OncoDNA and myNEO Join Forces to Unlock the Power of mRNA Therapeutics

por OncoDNA

The companies will combine their advanced technologies to provide an individualized vaccine design for patients with no treatment options

Leer más

Understanding the nanotechnology in COVID-19 vaccines

por CAS, a division of the American Chemical Society

Lipid nanoparticles are a vital component of the new Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting the mRNA effectively to the right place in ce...

Leer más

Pall Corporation Invests $114M to Expand Global Production Capacity

por Pall Biotech

Pall Corporation expands production capacity in the United States and Europe to support industry demand

Leer más

Oh, what a year it’s been! Lessons learned amid the pandemic

por CAS, a division of the American Chemical Society

We began 2020 refreshed and hopeful, with plans to publish unique perspectives and insights to inspire new ideas in the months to come—but COVID-19 changed everything. As the world adapted and recon...

Leer más

Sartorius raises forecast for the full year of 2020

por Sartorius Stedim Spain

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged

Leer más

Telstar MSC in TV NBC News report

por Telstar

Telstar microbiological safety cabinets are present in the most prominent laboratories around the world which are working on the research for vaccines to treat or prevent Covid-19.

Leer más

The manufacturing process for Strangvac, the new vaccine against equine strangles, is proceeding according to plan

por 3P Biopharmaceuticals

The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in complian...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Palobiofarma anuncia la finalización de...

by Palobiofarma

Palobiofarma S.L. se complace en anunciar la finalización del tratami...

Diapositiva de Fotos